GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
tioconazole is an approved drug
Compound class:
Synthetic organic
Comment: Tioconazole is an antifungal drug.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
In fungi and yeast the molecular target of tioconazole is the cytochrome P450 enzyme lanosterol 14-α demethylase (CYP51 or ERG11) which converts lanosterol to the crucial cell wall component ergosterol. Without ergosterol the pathogens are unable to survive. Tioconazole also inhibits activity of the human P450 enzyme CYP8B1 that participates in a branch of the bile acid biosynthesis pathway [2]. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Targets where the ligand is described in the comment field | |
Target | Comment |
CYP8B1 | Converts 7α-hydroxycholest-4-en-3-one to 7-alpha,12α-dihydroxycholest-4-en-3-one (in rabbit) [1] in the biosynthesis of bile acids. The azole antifungal drugs miconazole, econazole and tioconazole inhibit the native reaction of human CYP8B1 [2]. CYP8B1 inhibition offers potential in the treatment of metabolic (fatty) liver disease and diabetes [2]. |